As part of our COVID-19 Impact Series, we have been exploring potential impacts to our nationwide network of health system specialty pharmacies. Read More >

News

Discover the latest articles and industry news about health system specialty pharmacy, Excelera and the Excelera Network.

Specialty Pharmacy Continuum

Specialty Drugs Remain A Robust Market Force

Less than 1% of Americans use specialty drugs, yet the medications now account for 38% of the nation’s pharmacy drug spending. The figure is expected to rise further as more orphan and other specialty drugs pass through the regulatory pipeline, according to speakers at the Academy of Managed Care Pharmacy’s AMCP 2016 meeting.

Read article
American Journal of Health-System Pharmacy

Benefits of developing a collaborative, outcomes-based specialty pharmacy program

The collaborative development of practice standards, service requirements, and patient management protocols offers the rapid elevation of specialty pharmacy services, which provides significant differentiation within the highly competitive specialty pharmacy and third-party payer marketplaces.

Read article
Benzinga

Specialty Pharmacy Times Teams Up with ExceleraRx Corp in Strategic Alliance Partnership

Specialty Pharmacy Times, a bi-monthly journal and daily news website serving the business and practice of specialty pharmaceuticals and therapy, has expanded its Strategic Alliance Partnership program with the addition of the Excelera Specialty Pharmacy Network, a unique national network of academic institutions and large integrated delivery systems-based specialty pharmacies providing coordinated care to drive higher quality outcomes with complex patients.

Read article
American Journal of Health-System Pharmacy

Management of multiple sclerosis and the integration of related specialty pharmacy programs within health systems

Pharmacists in integrated health-system programs can play a significant role in assisting patients with MS manage their disease efficiently and safely by educating them about their therapies, ensuring compliance with the associated risk evaluation and mitigation strategy (REMS) program, and helping them access these therapies in a timely manner.

Read article
TEDx

The New “Disrupters” in Healthcare – Patients and Pharmacists [Video]

Dr. Rajiv Shah’s recent TEDx talk highlighted the growing importance of pharmacists in the care of complex patients. Dr. Shah is the CEO of MyMeds (www.my-meds.com), a digital health company whose medication adherence platform engages patients, physicians and pharmacists to work together.

Read article
University of MN, College of Pharmacy

Impact of Comprehensive Medication Management on Patients Health

The College of Pharmacy is a collaborator on a $2.4 million grant awarded by the American College of Clinical Pharmacy (ACCP) and the ACCP Research Institute to study the impact of implementing comprehensive medication management (CMM) in contemporary primary care medical practices.

Read article
Specialty Pharmacy Continuum

Hospitals Continue Move Into Specialty Pharmacy

It may not be time to worry about health systems grabbing a major chunk of the specialty pharmacy market, but the trade channel continues to make steady gains in becoming more of a key player in this highly competitive landscape.

Read article
American Journal of Health-System Pharmacy

Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis

An integrated pharmacy practice model that includes an interdisciplinary team of physicians, nurses, and pharmacists improved patient compliance with MS therapies.

Read article
Pharmaceutical Commerce

Six factors driving new specialty pharmacies

Specialty drugs will account for 50% of total US drug spending within five years. The projected growth is drawing many companies into the business of dispensing specialty drugs. The new entrants will increase competition and challenge manufacturers’ channel strategies.

Read article
Pharmaceutical Commerce

New pharmacy models drive new data needs

New pharmacy models and data needs are beginning to emerge from the macro changes occurring in US healthcare. Healthcare reform has accelerated the drive to create new care delivery and payment models. Specialty drugs are rapidly increasing their proportion of the overall US drug spend.

Read article


LinkedIn icon